ACET FY 2015 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$69M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$510M+2.1% YoY

Gross Profit

$115M22.5% margin

Operating Income

$44M8.7% margin

Net Income

$29M5.7% margin

EPS (Diluted)

$18.56

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$24M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$490M

Total Liabilities

$236M

Stockholders' Equity

$254M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$510M	$500M	+2.1%
Gross Profit	$115M	$98M	+16.7%
Operating Income	$44M	$34M	+28.6%
Net Income	$29M	$22M	+29.9%